LSZ 150 mcg Blotters (Lysergic Acid Derivative) – Scientific Product Description

Introduzione

LSZ (Lysergic Acid 2,4-dimethylazetidide) is a semi-synthetic lysergamide, structurally related to LSD. These 150 mcg blotters were developed for use in strictly controlled laboratory environments and are intended for research into the pharmacological properties O psychedelic compounds. Production takes place under strict quality control.

Specifiche tecniche

• Active ingredient: LSZ (Lysergic Acid 2,4-dimethylazetidide)
• Dosage per blotter: 150 ± 5 mcg
• Blotter size: 5×5 mm, perforated squares
• Carrier medium: High-quality chromatography paper
• Purezza: ≥98% (analizzato tramite HPLC)
• Shelf life: 24 months when stored between 2–8°C in a light-proof container.

Applicazioni di ricerca

LSZ blotters are used in:

• Receptor binding studies targeting 5-HT2A agonism
• Comparative pharmacological analysis within the lysergamide class
• Dose-response studies in controlled models
• Metabolic stability studies in vitro

Quality control

Each batch is subjected to:

• HPLC-UV quantification of active substance
• Confirmation via mass spectrometry
• Dosage uniformity analysis
• Microbiological control of the carrier material

Protocollo di sicurezza

Gestione

• Use nitrile gloves for all handling
• Avoid direct contact with skin
• Work only in a controlled laboratory environment
• Wear protective clothing, goggles and, if necessary, respiratory protection

Magazzinaggio

• Temperature: 2–8°C
• Protection from light and moisture is required
• Use only the original, sealed packaging

Quadro normativo

• Classified under the Dutch Opium Act (Schedule I)
• Only permitted for licensed research institutions
• Not suitable for human consumption
• Export and distribution subject to regulations

Informazioni sull'ordine

• Packaging unit: 10 blotters per sheet
• Delivery: Refrigerated transport with temperature registration
• Documentation: COA and full analytical specifications available per batch

Scientific References

• Nichols (2016) – Gli psichedelici come medicinali
• Brandt e altri (2020) – Farmacologia della lisergamide
• OEDT (2023) – Rapporto tecnico sulle nuove sostanze psicoattive

Important Note

This product is intended solely for legally authorized scientific research. Sale and use are restricted to qualified professionals within a regulated research environment. The purchaser is solely responsible for compliance with applicable laws and regulations.

1cP-LSD 150 MCG Art Blotters Pellet di O-DSMT da 50 mg Blotter 1V-LSD 150 MCG 6-CL-ADBA 2-CMC 250 mg in pellet